DAVITA INC. FILES 8-K ON FINANCIAL RESULTS, OPERATIONS

Ticker: DVA · Form: 8-K · Filed: 2024-02-13T00:00:00.000Z

Sentiment: neutral

Topics: financial-results, 8-K, operations, disclosure

TL;DR

**DaVita just dropped an 8-K with fresh financial results, so check their numbers!**

AI Summary

DaVita Inc. filed an 8-K on February 13, 2024, to report its results of operations and financial condition. This filing, under Items 2.02 and 9.01, indicates that the company is providing updated financial information, likely related to its recent earnings or a significant financial event. For investors, this matters because it provides crucial, timely data about the company's financial health and performance, which can influence stock valuation and future investment decisions.

Why It Matters

This filing provides investors with the latest financial performance data for DaVita Inc., which is essential for evaluating the company's health and making informed investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results, which is standard practice and generally does not introduce new risks.

Analyst Insight

A smart investor would review the full financial statements and exhibits referenced in this 8-K to understand the specific details of DaVita Inc.'s reported results and financial condition, as this summary only indicates the filing of such information.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by DaVita Inc.?

The purpose of this 8-K filing by DaVita Inc. is to report on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as per Item 2.02 and Item 9.01, respectively, with the earliest event reported on February 13, 2024.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 13, 2024.

What is DaVita Inc.'s trading symbol and on which exchange is its common stock registered?

DaVita Inc.'s trading symbol is DVA, and its Common Stock, $0.001 par value, is registered on the New York Stock Exchange.

What is the business address and phone number for DaVita Inc. as listed in the filing?

The business address for DaVita Inc. is 2000 16th Street, Denver, CO 80202, and its business phone number is (720) 631-2100.

Under which items of Form 8-K were the disclosures made?

The disclosures were made under 'ITEM INFORMATION: Results of Operations and Financial Condition' and 'ITEM INFORMATION: Financial Statements and Exhibits', corresponding to Item 2.02 and Item 9.01 respectively.

From the Filing

0000927066-24-000005.txt : 20240213 0000927066-24-000005.hdr.sgml : 20240213 20240213161116 ACCESSION NUMBER: 0000927066-24-000005 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240213 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 24625970 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva-20240213.htm 8-K dva-20240213 0000927066 false 0000927066 2024-02-13 2024-02-13   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (date of earliest event reported): February 13, 2024     DAVITA INC. (Exact name of registrant as specified in its charter)   DE 1-14106 51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   2000 16th Street Denver, CO 80202 (Address of principal executive offices including Zip Code)   ( 720 ) 631-2100 (Registrant’s telephone number, including area code)   Not applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class:   Trading symbol(s): Name of each exchange on which registered: Common Stock, $0.001 par value   DVA New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐     Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02. Results of Operations and Financial Condition.   On February 13, 2024, DaVita Inc. (the "Company") issued a press release announcing its financial results for the quarter ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this report.   The information contained in this Item 2.02 (including Exhibit 99.1 attached hereto) is being furnished and shall not be

View on Read The Filing